BioCentury
ARTICLE | Company News

Merck KGaA genitourinary news

December 9, 2013 8:00 AM UTC

The EMD Serono Inc. subsidiary of Merck launched TocopheRx (Boston, Mass.) to develop the pharma's preclinical oral follicle-stimulating hormone (FSH) agonists to treat infertility. EMD Serono will p...